More Orthocell Ltd news Orthocell LtdASX: OCC Ethics Approval Received for Pilot Ortho-ATI Tendon Study Apr 30, 2017 at 11:30 PM EDT · Issued by Orthocell Ltd Filed with ASX · Apr 30, 2017 at 11:30 PM EDTOn 6ix: 6ix.com/news/ethics-approval-received-for-pilot-ortho-ati-tendon-studyOrthocell Ltd has released a press release. View Attachment6ix hasn’t read this filing yet. Read this filing Orthocell Ltd on 6ix Story so farSingapore Patent for CelGro SMART Graft ReceivedMar 28, 2017Approval for CelGro Human Nerve Regeneration Study ReceivedOct 18, 2016Ethics Approval for Pivotal Ortho ATI Tendon Study ReceivedJul 12, 2016 Earlier from OrthocellResponse to ASX QueryApr 10, 2017Singapore Patent for CelGro SMART Graft ReceivedMar 27, 2017Orthocell Announces Gluteal Tendon PublicationFeb 26, 2017Initial Results Positive for CelGro Human Nerve RegenerationFeb 21, 2017Orthocell Submits US Regulatory Application for CelGroFeb 7, 2017Later from OrthocellOrtho-ACI on Australian Register of Therapeutic GoodsMay 29, 2017Preliminary Final ReportAug 31, 20171st Patient Recruited in Ortho-ATI Shoulder Tendon StudySep 4, 2017Celgro Positive Safety and Performance in Human Hip StudySep 5, 2017Surgical Specialties Appointed as Exclusive DistributorOct 10, 2017All Orthocell news releases↗Follow Orthocell into a list and get an email when it puts out news.Follow Orthocell